# AAA Pharma GmbH Company profile · SME (from the award notice) - Legal form: GmbH - Seat: Böblingen, Germany Based on the notices and sources Inteliwert covers; not a complete record. Last checked 1 April 2026. ## Identifiers - Register entry: HRB 732259 As the covered sources state them. ## Track record in public tenders Awards in the covered notices over the last 36 months, per CPV division. | CPV division | Awards | Award value (excl. VAT) | Buyers | Repeat buyers | First award | Last award | | --- | ---: | ---: | ---: | ---: | --- | --- | | 33 Medical equipments, pharmaceuticals and personal care products | 1 | — | 1 | 0 | 1 April 2026 | 1 April 2026 | Based on the notices and sources Inteliwert covers; not a complete record. ### Awards - [Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Rivaroxaban, ATC B01AF01 für die Zeit 01.04.2026 - 30.06.2026](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi) Buyer: DAK-Gesundheit · Awarded: 1 April 2026 · CPV 33600000 ## Certifications and prequalification No certification or prequalification found in the covered sources. A certification missing here is unknown, not absent. ## Website and LinkedIn Not found in the indexed notices. ## Open tenders that might fit *Possible match based on public information* Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances. - [Germanium-68/Gallium-68 Generatoren](https://inteliwert.com/tender/opp_9XSVRV2NBZ9DSDM7MJT1H6E699/germanium-68-gallium-68-generatoren) Open · SME (from the award notice) · New to public tenders · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/7ac8d969bec05b9c), Last checked 9 Nov 2026, 06:31 (UTC+01:00) - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026 - Seat in the same federal state as the place of performance: [Evidence](https://inteliwert.com/company/org_5XEVZ1NPN87R8N1DRS388WV2MV), checked 9 Nov 2026 - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026 - [Arzneimittelverträge mit Beitrittsoption](https://inteliwert.com/tender/opp_ZRCHA0D7RV1FXHV0ZGJ7F015SG/arzneimittelvertraege-mit-beitrittsoption) Open · SME (from the award notice) · New to public tenders · Buyer: BARMER Beschaffung und Vergabe · Deadline: 1 Nov 2027, 12:00 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/d1305fd9-8e8c-4550-ad99-a30b2bb14d16), Last checked 8 Nov 2026, 16:30 (UTC+01:00) - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026 - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_5XEVZ1NPN87R8N1DRS388WV2MV), checked 8 Nov 2026 - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026 - [Arzneimittelverträge mit Beitrittsoption](https://inteliwert.com/tender/opp_DGM8H91ZA3P1C23NX55E16662G/arzneimittelvertraege-mit-beitrittsoption) Open · SME (from the award notice) · New to public tenders · Buyer: BARMER Beschaffung und Vergabe · Deadline: 1 Feb 2028, 07:04 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/eff32508-c459-43f7-96fa-5caeab05b965), Last checked 8 Nov 2026, 18:30 (UTC+01:00) - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026 - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_5XEVZ1NPN87R8N1DRS388WV2MV), checked 8 Nov 2026 - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026 - [Arzneimittelverträge mit Beitrittsoption](https://inteliwert.com/tender/opp_0MWC2T4YWKEJTQCGBN2VPYH223/arzneimittelvertraege-mit-beitrittsoption) Open · SME (from the award notice) · New to public tenders · Buyer: BARMER Beschaffung und Vergabe · Deadline: 1 May 2028, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/1f77835c-0c62-4d4c-8ca7-ec1e94aaddcf), Last checked 8 Nov 2026, 18:30 (UTC+01:00) - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026 - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_5XEVZ1NPN87R8N1DRS388WV2MV), checked 8 Nov 2026 - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026 - [Arzneimittelverträge mit Beitrittsoption](https://inteliwert.com/tender/opp_XP02DC2C8WEMJT9KP6QDSF3KD5/arzneimittelvertraege-mit-beitrittsoption) Open · SME (from the award notice) · New to public tenders · Buyer: BARMER Beschaffung und Vergabe · Deadline: 1 Sept 2028, 11:38 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/5fe4d262-5ec0-427d-9d9e-6aefa98462fd), Last checked 8 Nov 2026, 21:31 (UTC+01:00) - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026 - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_5XEVZ1NPN87R8N1DRS388WV2MV), checked 8 Nov 2026 - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026 - [Arzneimittelverträge mit Beitrittsoption](https://inteliwert.com/tender/opp_50F6EM20DZ5WERPQEKQ5FHV6YW/arzneimittelvertraege-mit-beitrittsoption) Open · SME (from the award notice) · New to public tenders · Buyer: BARMER Beschaffung und Vergabe · Deadline: 1 Sept 2028, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/c7967b45-258b-4d12-a97f-5e9b187dd166), Last checked 8 Nov 2026, 21:31 (UTC+01:00) - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026 - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_5XEVZ1NPN87R8N1DRS388WV2MV), checked 8 Nov 2026 - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026 - [Arzneimittelverträge mit Beitrittsoption](https://inteliwert.com/tender/opp_3B37YPRMWMVADZ72RJ58NE5ASW/arzneimittelvertraege-mit-beitrittsoption) Open · SME (from the award notice) · New to public tenders · Buyer: BARMER Beschaffung und Vergabe · Deadline: 1 Sept 2028, 12:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/98688879-0d9d-4349-9d7d-93247e73e0fe), Last checked 8 Nov 2026, 21:31 (UTC+01:00) - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026 - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_5XEVZ1NPN87R8N1DRS388WV2MV), checked 8 Nov 2026 - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 8 Nov 2026 - [Open House Originale Rabattverträge 2025-05 - Emtricitabin/Tenofovirdisoproxil/Rilpivirin (Wirkstoffkombination)](https://inteliwert.com/tender/opp_SE9778W0M0TDWPM20QNS2PM3VS/open-house-originale-rabattvertraege-2025-05-emtricitabin-tenofovirdisoproxil-ri) Open · SME (from the award notice) · New to public tenders · Buyer: Techniker Krankenkasse · Deadline: 30 Nov 2026, 23:58 (UTC+01:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/581490b8-248a-4903-bcf9-93fbed29074c), Last checked 9 Nov 2026, 03:31 (UTC+01:00) - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026 - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_5XEVZ1NPN87R8N1DRS388WV2MV), checked 9 Nov 2026 - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026 - [Open-House-Rabattverträge 2025-02](https://inteliwert.com/tender/opp_1T21VKVY20PM9NJ4J6RDVSSEKF/open-house-rabattvertraege-2025-02) Open · SME (from the award notice) · New to public tenders · Buyer: Techniker Krankenkasse · Deadline: 31 Mar 2027, 23:58 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/be2aa51e-1f48-42bf-ba4d-99c5b53f5417), Last checked 9 Nov 2026, 03:31 (UTC+01:00) - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026 - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_5XEVZ1NPN87R8N1DRS388WV2MV), checked 9 Nov 2026 - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026 - [Open-House-Rabattverträge 2025-08](https://inteliwert.com/tender/opp_G4B13XMSNC7R2WHPR8XQPFFPEE/open-house-rabattvertraege-2025-08) Open · SME (from the award notice) · New to public tenders · Buyer: Techniker Krankenkasse · Deadline: 31 Aug 2027, 23:58 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/a73159b8-dcf7-47d6-8f60-df40be85dc0d), Last checked 9 Nov 2026, 03:31 (UTC+01:00) - Won a contract in CPV group 336 (2026-04-01): [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026 - Seat in the same country as the place of performance: [Evidence](https://inteliwert.com/company/org_5XEVZ1NPN87R8N1DRS388WV2MV), checked 9 Nov 2026 - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_PMR0Q06AJV2HG0BSPEK4ZPPWYQ/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-abs-8-sgb-v-zum-wi), checked 9 Nov 2026 ## Is this your company? Send corrections, or ask us to remove the profile, to . You can also ask that the company never be tagged on LinkedIn. ## About this profile Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances. **Based on the notices and sources Inteliwert covers; not a complete record.** Last checked 1 April 2026. --- Page: https://inteliwert.com/company/org_5XEVZ1NPN87R8N1DRS388WV2MV/aaa-pharma-gmbh Inteliwert is a product of Bandpey GmbH, an international data and AI software company in Munich, Germany, founded and led by Roozbeh Bandpey. Bandpey's products: Facthory, Emolysis, Copolly and Inteliwert. Inteliwert on LinkedIn: https://www.linkedin.com/company/intelliwert, GitHub: https://github.com/inteliwertai.